PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies
PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and evaluation of suspected recurrence. The goal of this 6-part series of review articles is to provide practical information to providers and imaging professional...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/23/5941 |
| _version_ | 1797463516656959488 |
|---|---|
| author | Ahmed Ebada Salem Harsh R. Shah Matthew F. Covington Bhasker R. Koppula Gabriel C. Fine Richard H. Wiggins John M. Hoffman Kathryn A. Morton |
| author_facet | Ahmed Ebada Salem Harsh R. Shah Matthew F. Covington Bhasker R. Koppula Gabriel C. Fine Richard H. Wiggins John M. Hoffman Kathryn A. Morton |
| author_sort | Ahmed Ebada Salem |
| collection | DOAJ |
| description | PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and evaluation of suspected recurrence. The goal of this 6-part series of review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for the more common adult malignancies. In the first article of this series, hematologic malignancies are addressed. The classification of these malignancies will be outlined, with the disclaimer that the classification of lymphomas is constantly evolving. Critical applications, potential pitfalls, and nuances of PET-CT imaging in hematologic malignancies and imaging features of the major categories of these tumors are addressed. Issues of clinical importance that must be reported by the imaging professionals are outlined. The focus of this article is on [<sup>18</sup>F] fluorodeoxyglucose (FDG), rather that research tracers or those requiring a local cyclotron. This information will serve as a resource for the appropriate role and limitations of PET-CT in the clinical management of patients with hematological malignancy for health care professionals caring for adult patients with hematologic malignancies. It also serves as a practical guide for imaging providers, including radiologists, nuclear medicine physicians and their trainees. |
| first_indexed | 2024-03-09T17:51:50Z |
| format | Article |
| id | doaj.art-ee1ff336dcdc47f4b1b3db7df3ae5411 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-09T17:51:50Z |
| publishDate | 2022-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-ee1ff336dcdc47f4b1b3db7df3ae54112023-11-24T10:41:11ZengMDPI AGCancers2072-66942022-11-011423594110.3390/cancers14235941PET-CT in Clinical Adult Oncology: I. Hematologic MalignanciesAhmed Ebada Salem0Harsh R. Shah1Matthew F. Covington2Bhasker R. Koppula3Gabriel C. Fine4Richard H. Wiggins5John M. Hoffman6Kathryn A. Morton7Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Medicine, Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USAPET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and evaluation of suspected recurrence. The goal of this 6-part series of review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for the more common adult malignancies. In the first article of this series, hematologic malignancies are addressed. The classification of these malignancies will be outlined, with the disclaimer that the classification of lymphomas is constantly evolving. Critical applications, potential pitfalls, and nuances of PET-CT imaging in hematologic malignancies and imaging features of the major categories of these tumors are addressed. Issues of clinical importance that must be reported by the imaging professionals are outlined. The focus of this article is on [<sup>18</sup>F] fluorodeoxyglucose (FDG), rather that research tracers or those requiring a local cyclotron. This information will serve as a resource for the appropriate role and limitations of PET-CT in the clinical management of patients with hematological malignancy for health care professionals caring for adult patients with hematologic malignancies. It also serves as a practical guide for imaging providers, including radiologists, nuclear medicine physicians and their trainees.https://www.mdpi.com/2072-6694/14/23/5941imagingFDGpositron emission tomographyPETlymphomaleukemia |
| spellingShingle | Ahmed Ebada Salem Harsh R. Shah Matthew F. Covington Bhasker R. Koppula Gabriel C. Fine Richard H. Wiggins John M. Hoffman Kathryn A. Morton PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies Cancers imaging FDG positron emission tomography PET lymphoma leukemia |
| title | PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies |
| title_full | PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies |
| title_fullStr | PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies |
| title_full_unstemmed | PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies |
| title_short | PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies |
| title_sort | pet ct in clinical adult oncology i hematologic malignancies |
| topic | imaging FDG positron emission tomography PET lymphoma leukemia |
| url | https://www.mdpi.com/2072-6694/14/23/5941 |
| work_keys_str_mv | AT ahmedebadasalem petctinclinicaladultoncologyihematologicmalignancies AT harshrshah petctinclinicaladultoncologyihematologicmalignancies AT matthewfcovington petctinclinicaladultoncologyihematologicmalignancies AT bhaskerrkoppula petctinclinicaladultoncologyihematologicmalignancies AT gabrielcfine petctinclinicaladultoncologyihematologicmalignancies AT richardhwiggins petctinclinicaladultoncologyihematologicmalignancies AT johnmhoffman petctinclinicaladultoncologyihematologicmalignancies AT kathrynamorton petctinclinicaladultoncologyihematologicmalignancies |